Lineage Cell Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of LCTX for the last quarter is 1.41 M USD, and it's 2.49% lower compared to the previous quarter. The net income of Q2 24 is -5.76 M USD.